JP2023533015A5 - - Google Patents
Info
- Publication number
- JP2023533015A5 JP2023533015A5 JP2023501000A JP2023501000A JP2023533015A5 JP 2023533015 A5 JP2023533015 A5 JP 2023533015A5 JP 2023501000 A JP2023501000 A JP 2023501000A JP 2023501000 A JP2023501000 A JP 2023501000A JP 2023533015 A5 JP2023533015 A5 JP 2023533015A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- inhibitor
- cancer
- cabozantinib
- axitinib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20184962 | 2020-07-09 | ||
| EP20184962.7 | 2020-07-09 | ||
| PCT/EP2021/068564 WO2022008469A1 (en) | 2020-07-09 | 2021-07-06 | Combination of a methionine aminopeptidase 2 inhibitor and vegfr/vegf inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533015A JP2023533015A (ja) | 2023-08-01 |
| JP2023533015A5 true JP2023533015A5 (https=) | 2024-07-09 |
| JP7791163B2 JP7791163B2 (ja) | 2025-12-23 |
Family
ID=71575014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501000A Active JP7791163B2 (ja) | 2020-07-09 | 2021-07-06 | メチオニンアミノペプチダーゼ２阻害剤とｖｅｇｆｒ／ｖｅｇｆ阻害剤の組み合わせ（がん治療薬の組み合わせ） |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230248695A1 (https=) |
| EP (1) | EP4178572A1 (https=) |
| JP (1) | JP7791163B2 (https=) |
| KR (1) | KR20230038219A (https=) |
| CN (1) | CN115989027A (https=) |
| AU (1) | AU2021303438B2 (https=) |
| BR (1) | BR112022025030A2 (https=) |
| CA (1) | CA3186322A1 (https=) |
| IL (1) | IL299715A (https=) |
| MX (1) | MX2022016060A (https=) |
| WO (1) | WO2022008469A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010048374A1 (de) | 2010-10-13 | 2012-04-19 | Merck Patent Gmbh | Pyrrolidinone als MetAP-2 Inhibitoren |
| DE102012006884A1 (de) | 2012-04-04 | 2013-10-10 | Merck Patent Gmbh | Cyclische Amide als MetAP-2 Inhibitoren |
| KR102485537B1 (ko) * | 2014-08-04 | 2023-01-05 | 메르크 파텐트 게엠베하 | Metap-2 저해제로서의 피롤리디논 유도체 |
-
2021
- 2021-07-06 BR BR112022025030A patent/BR112022025030A2/pt unknown
- 2021-07-06 AU AU2021303438A patent/AU2021303438B2/en active Active
- 2021-07-06 KR KR1020237003949A patent/KR20230038219A/ko active Pending
- 2021-07-06 CN CN202180049064.9A patent/CN115989027A/zh active Pending
- 2021-07-06 EP EP21739377.6A patent/EP4178572A1/en active Pending
- 2021-07-06 JP JP2023501000A patent/JP7791163B2/ja active Active
- 2021-07-06 US US18/004,314 patent/US20230248695A1/en active Pending
- 2021-07-06 MX MX2022016060A patent/MX2022016060A/es unknown
- 2021-07-06 WO PCT/EP2021/068564 patent/WO2022008469A1/en not_active Ceased
- 2021-07-06 CA CA3186322A patent/CA3186322A1/en active Pending
- 2021-07-06 IL IL299715A patent/IL299715A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532374A5 (https=) | ||
| KR20240055778A (ko) | Tead 억제제를 포함하는 제약 조합물 및 암의 치료를 위한 이의 용도 | |
| JP2024526145A5 (https=) | ||
| CN108601831B (zh) | 一种抗pd-1抗体和vegfr抑制剂联合在制备治疗癌症的药物中的用途 | |
| JP2014525454A5 (https=) | ||
| JP2019517549A5 (https=) | ||
| TW201922793A (zh) | Ｐｄ－１抗體和ｖｅｇｆｒ抑制劑聯合治療小細胞肺癌的用途 | |
| JP5788527B2 (ja) | キナーゼ阻害剤の副作用低減剤 | |
| AR094654A1 (es) | Modulador del receptor de andrógeno y sus usos, método para tratamiento, composición farmacéutica | |
| US20230181565A1 (en) | Crenolanib combination therapy | |
| RU2018140055A (ru) | Способ лечения почечно-клеточного рака с использованием n-(4-(6,7-диметоксихинолин-4-илокси)фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида, (2s)-гидроксибутандиоата | |
| JP2023533464A5 (https=) | ||
| TWI877433B (zh) | 用於治療ｐｉｋ３ｃａ突變癌症的組合療法 | |
| JP2022510962A5 (https=) | ||
| JP2023550149A5 (https=) | ||
| CN117957000A (zh) | 药物组合物及其用途 | |
| CN112043702A (zh) | 用于联合治疗结直肠癌的喹啉类化合物 | |
| RU2015138576A (ru) | Комбинации соединения ингибитора мек с соединением ингибитором her3/egfr и способы применения | |
| JP2023533015A5 (https=) | ||
| CN116159062A (zh) | 药物组合物及其用途 | |
| CN104394865B (zh) | 稳定性提高的包含氨氯地平和氯沙坦的组合物 | |
| CA3141174A1 (en) | Quinoline derivatives for treatment of head and neck cancer | |
| JP2025508548A5 (https=) | ||
| WO2024205477A1 (en) | Method for treating liver cancers using fostroxacitabine bralpamide, an immune checkpoint inhibitor and a vegf antagonist | |
| HK40093376A (en) | Combination therapy for treating pik3ca-mutated cancer |